LEVRACETAM, created in 2007 (Belgium), from 359 sister brands and 2214 competing brands. The LEVRACETAM brand is owned by UCB, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0003739530. LEVRACETAM is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
UCB
(LEVRACETAM)
over 5 years*
EUR 208.47